Zobrazeno 1 - 10
of 315
pro vyhledávání: '"Statin induced myopathy"'
Autor:
Ciobanu Elena Cosmina, Ungurenasu Andreea Simona, Haba Mihai Ștefan Cristian, Petris Antoniu Octavian, Mitu Ovidiu
Publikováno v:
Romanian Journal of Cardiology, Vol 32, Iss 1, Pp 41-45 (2022)
Though rare, statins can produce serious adverse effects with clinical implications that urge prompt intervention. However, in high-risk patients that require intense hypolipemiant treatment, such situations can be challenging and require complimenta
Externí odkaz:
https://doaj.org/article/549fb0bb8e424a0c91b818ccfc452d12
Publikováno v:
Клинический разбор в общей медицине, Vol 2, Iss 10, Pp 10-13 (2021)
Statins are widely used in patients with cardiovascular disorders. However, the issue of the feasibility of prescribing the high-dose and medium-dose statins to elderly patients remains a matter of discussion. That is due to higher prevalence of the
Externí odkaz:
https://doaj.org/article/b8299bac70904665ab4161c6c7ec7cfc
Publikováno v:
Romanian Journal of Medical Practice, Vol 16, Iss 2, Pp 146-150 (2021)
Statins are the most frequently used drugs for lowering the low density lipoprotein (LDL)-cholesterol and are proven to decrease the cardiovascular-driven mortality. The statin-induced myopathy represents a side effect of the statin therapy and inclu
Externí odkaz:
https://doaj.org/article/1ddb5c30ca52494b9d64829fc6df5578
Autor:
Mohamed H. Al-Sabri, Neha Behare, Ahmed M. Alsehli, Samuel Berkins, Aadeya Arora, Eirini Antoniou, Eleni I. Moysiadou, Sowmya Anantha-Krishnan, Patricia D. Cosmen, Johanna Vikner, Thiago C. Moulin, Nourhene Ammar, Hadi Boukhatmi, Laura E. Clemensson, Mathias Rask-Andersen, Jessica Mwinyi, Michael J. Williams, Robert Fredriksson, Helgi B. Schiöth
Publikováno v:
Cells, Vol 11, Iss 22, p 3528 (2022)
The underlying mechanisms for statin-induced myopathy (SIM) are still equivocal. In this study, we employ Drosophila melanogaster to dissect possible underlying mechanisms for SIM. We observe that chronic fluvastatin treatment causes reduced general
Externí odkaz:
https://doaj.org/article/d87b7b6fdc5541df9494759d713adeac
Publikováno v:
Безопасность и риск фармакотерапии, Vol 7, Iss 4, Pp 163-175 (2019)
The widespread use of statins in clinical practice necessitates a systematic approach to the risk and safety assessment. The aim of the study was to analyze information about adverse reactions to statins and their specific causes in patients with hyp
Externí odkaz:
https://doaj.org/article/73dfd9f33159483ea1047b34e5812d25
Autor:
Ann Abdel Kader, Radwa Azmy, Eman A. Maher, Basma Bahgat El Sayed, Alshaimaa Sobhi Khalil, Mohammad Ghalwash, Manal Mahmoud
Publikováno v:
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, Vol 55, Iss 1, Pp 1-6 (2019)
Abstract Background Statin-induced myopathy is the most common adverse effect of statins. Bee venom provides a potential mean of controlling immune responses and inflammatory reactions; the proposed mechanisms for statin-induced myopathy. Objective T
Externí odkaz:
https://doaj.org/article/a7d04b6891224749bac02ce12f514de3
Autor:
Frederik Peters, Jenny Kuchenbecker, Thea Kreutzburg, Ursula Marschall, E. Sebastian Debus, Christian‐Alexander Behrendt
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 22 (2020)
Background An increasing number of patients with a peripheral arterial occlusive disease were put on statins during the past years. This study assessed whether statin therapy was effective and safe for these new users. Methods and Results Using healt
Externí odkaz:
https://doaj.org/article/160e96bb71f5409ba2a14761f36501f1
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives, Vol 9, Iss 1, Pp 33-35 (2019)
Statins are commonly used lipid lowering agents which play a pivotal role in reducing cardiovascular morbidity and mortality. Often well tolerated, these HMG-CoA reductase (HMGCR) inhibitors can sometimes cause severe muscle weakness and elevated cre
Externí odkaz:
https://doaj.org/article/54e062de2f4645cc82f4059c7b2494f5
Autor:
Krista D. Riche, Pharm.D., Justin Arnall, Pharm.D., Kristin Rieser, Pharm.D., Honey E. East, M.D., Daniel M. Riche, Pharm.D., FCCP, BCPS, CDE, ASH-CHC, CLS
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 6, Iss C, Pp 56-59 (2016)
Introduction: There is a multitude of evidence supporting the benefit of statin use in cardiovascular disease; however, statin-induced myopathy is a major reason for statin discontinuation and non-adherence. Vitamin D deficiency has been independentl
Externí odkaz:
https://doaj.org/article/4b9f94f4a8ab4867a3adda0dbc817233
Autor:
Valentin Nicolae Varlas, Mirela Marioara Toma, Gabriela Anca Angelescu, Pharmacy, Bucharest, Romania
Publikováno v:
Romanian Journal of Medical Practice, Vol 16, Iss 2, Pp 146-150 (2021)
Statins are the most frequently used drugs for lowering the low density lipoprotein (LDL)-cholesterol and are proven to decrease the cardiovascular-driven mortality. The statin-induced myopathy represents a side effect of the statin therapy and inclu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54ac658dc9cb3d665ca2360375b583d5
https://rjmp.com.ro/articles/2021.2/RJMP_2021_2_Art-07.pdf
https://rjmp.com.ro/articles/2021.2/RJMP_2021_2_Art-07.pdf